Biocon posts Q4 FY24 PAT at Rs. 135 Cr
EBITDA for the quarter stood at Rs 964 crore, representing an EBITDA margin of 24%
EBITDA for the quarter stood at Rs 964 crore, representing an EBITDA margin of 24%
Glenmark’s Acetaminophen and Ibuprofen Tablets, 250 mg/125 mg (OTC), will be distributed in the U.S. by Glenmark Therapeutics, USA
The exclusive agreement between AAHI and Croda includes a collaborative effort in research and development
Vericiguat works on a pathway not currently targeted by existing heart failure treatments
Usnoflast (ZYIL1) is a novel oral small molecule NLRP3 inhibitor discovered at Zydus
Centhaquine is a resuscitative agent presently indicated for the treatment of hypovolemic shock by DGCI
Grand opening of the joint venture between Evonik China and Shandong Vland Biotech in Qingdao, China
The investment will catalyse various components of the IndiaAI Mission
Connecting new production and consumption areas of chilled food by low-carbon transportation services
Subscribe To Our Newsletter & Stay Updated